Assessing Folic Acid in High-Risk Pregnancy for Neural Tube Defects
NCT ID: NCT06135883
Last Updated: 2023-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
267 participants
OBSERVATIONAL
2023-02-20
2023-08-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Anterior Middle Brain Structures With Cerebrovascular Flow in Fetuses With Fetal Growth Restriction
NCT06215690
Uterocervical Angle in the Termination of Second Trimester Pregnancy
NCT03220607
Fetal Fibronectin as a Predictor of Successful Induction of Mid-trimester Abortion
NCT02694198
The Role of Uterine NK Cells and T Cell Cytokines in Recurrent Miscarriage
NCT01688284
Transabdominal Cervical Length Predict Preterm Labor During Routine Antenatal Screening
NCT04313673
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Case
Singleton pregnant women over the age of 18 and under the age of 45 who have at least one of the risk factors for neural tube defects (family history, MTHFR gene mutation, birth history with aneuploidy, history of GDM or known DM).
No interventions assigned to this group
Control
Singleton pregnant women over 18 years of age and under 45 years of age who do not have any risk factors for neural tube defects
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Under 45 years of age
* Having at least one of the risk factors for neural tube defects (family history, MTHFR gene mutation, birth defect with aneuploidy, history of GDM or known DM) for Case Group.
* Singleton pregnant women
Exclusion Criteria
* Above 45 years old
* Multiple pregnancies
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Karabuk University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cagdas Nurettin Emeklioglu
MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Prof. Dr. Cemil Tascioglu City Hospital
Istanbul, Sisli, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KBU-EMEKLIOĞLU-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.